Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...

The company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing.

The drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solut...